Dr. Ernesto Doncel-Pérez graduated in Biology from the University of Havana in 1990 and worked as a researcher at the Center for Genetic Engineering and Biotechnology (CIGB) until 1997. That year, he moved to Spain and completed a PhD at the National Center for Biotechnology (UAM), focusing on the RecU protein of Bacillus subtilis (awarded cum laude, 2001). As a postdoctoral researcher at the Cajal Institute (CSIC), he studied central nervous system (CNS) repair and developed antitumor agents for brain tumors.
Since 2008, he has worked at the National Hospital for Paraplegics in Toledo, where he founded the Neuro-Regenerative Chemistry Group and currently serves as Principal Investigator of the Neural Regeneration Group. He has led national and regional research projects (ISCIII, MINECO, MICIN), co-invented a patent related to CNS repair, and collaborates actively with research teams across Europe and Latin America.
Dr. Doncel-Pérez supervises graduate students and co-directs PhD theses. He coordinates the Guillain-Barré Syndrome patient sample collection (BioB-HUT) and leads the multicenter BioGBS project focused on the identification of novel biomarkers. His research is dedicated to understanding and modulating spinal cord injury pathophysiology and to developing effective diagnostic and therapeutic strategies for Guillain-Barré Syndrome.
Dr. Ernesto Doncel-Pérez graduated in Biology from the University of Havana in 1990 and worked as a researcher at the Center for Genetic Engineering and Biotechnology (CIGB) until 1997. That year, he moved to Spain and completed a PhD at the National Center for Biotechnology (UAM), focusing on the RecU protein of Bacillus subtilis (awarded cum laude, 2001). As a postdoctoral researcher at the Cajal Institute (CSIC), he studied central nervous system (CNS) repair and developed antitumor agents for brain tumors.
Since 2008, he has worked at the National Hospital for Paraplegics in Toledo, where he founded the Neuro-Regenerative Chemistry Group and currently serves as Principal Investigator of the Neural Regeneration Group. He has led national and regional research projects (ISCIII, MINECO, MICIN), co-invented a patent related to CNS repair, and collaborates actively with research teams across Europe and Latin America.
Dr. Doncel-Pérez supervises graduate students and co-directs PhD theses. He coordinates the Guillain-Barré Syndrome patient sample collection (BioB-HUT) and leads the multicenter BioGBS project focused on the identification of novel biomarkers. His research is dedicated to understanding and modulating spinal cord injury pathophysiology and to developing effective diagnostic and therapeutic strategies for Guillain-Barré Syndrome.